MAGELLAN LONGEVITY
HomeResearchStudy library › What are the potential therapeutic roles and molecular mechanisms of…
Study summary · NAD⁺, sirtuins & cellular energy

What are the potential therapeutic roles and molecular mechanisms of urolithins, particularly urolithin A, in various diseases and antiaging?

In one paragraph

Urolithin A, a laboratory study — a clinical trial showed urolithin A is safe up to 2,500 mg/day and improves mitochondrial biomarkers in elderly patients. The evidence comes from laboratory work, not from people. Source: Phytother Res 2021, PMID 34542202.

Source: Phytother Res 2021, PMID 34542202 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

Phytother Res · 2021 · PMID 34542202 · DOI 10.1002/ptr.7290

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Urolithins, derived from certain foods, show potential as therapeutic agents for various diseases and antiaging, partly by improving mitochondrial function.

The question

What are the potential therapeutic roles and molecular mechanisms of urolithins, particularly urolithin A, in various diseases and antiaging?

What they tested

Urolithins, gut metabolites from ellagitannin-rich foods, possess various biological activities including cardiovascular protection, anti-inflammatory, anticancer, antidiabetic, and antiaging properties, mediated by several cellular mechanisms.

How they did it

This is a comprehensive review of existing in vitro, in vivo, and clinical studies on urolithins, focusing on their biological effects, molecular pathways, and pharmacokinetics.

What they found

Urolithins exhibit beneficial effects in diseases like Alzheimer's, type 2 diabetes, liver disease, cardiovascular disease, and various cancers. Their mechanisms include inhibiting MDM2-p53 interaction, modulating the MAPK pathway, and suppressing NF-κB activity. Urolithin A's antiaging activity is linked to activating mitophagy and mitochondrial biogenesis. A clinical trial showed urolithin A is safe up to 2,500 mg/day and improves mitochondrial biomarkers in elderly patients.

What it means

Urolithins, particularly urolithin A, show promise as therapeutic agents due to their diverse biological activities and involvement in key cellular mechanisms, including mitophagy and mitochondrial biogenesis. Further clinical research is warranted.

Limitations

The abstract does not explicitly state limitations of the reviewed studies or the review itself, but it emphasizes the need for further clinical trials.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“urolithin A is safe and can improve mitochondrial biomarkers in elderly patients”— from the published abstract, Phytother Res 2021

The paper at a glance

Magellan’s evidence labelprecursor to urolithins, mitophagy (our label for this citation — see PubMed for the paper’s own title and authors)
JournalPhytother Res
Year2021
PMID34542202 ↗
DOI10.1002/ptr.7290 ↗
TopicNAD⁺, sirtuins & cellular energy

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Urolithin A (Mitopure)

In human research, urolithin A supplementation is safe and bioavailable and improves markers of mitochondrial health. Randomized trials report better muscle endurance in adults 65-90, roughly 12% strength gains with improved aerobic endurance in middle-aged adults, lower inflammatory markers (C-reactive protein…

Pomegranate Ellagitannin Extract

In human research, the ellagitannin-derived metabolite urolithin A has improved muscle strength, endurance, and biomarkers of mitochondrial function and inflammation in randomized trials of middle-aged and older adults, and a small 2025 trial found more youthful immune-cell profiles after four weeks, although several…

Urolithin A (Mitopure)

Urolithin A is a natural compound produced by gut bacteria from ellagitannins and ellagic acid, dietary…

Check price on Amazon ↗

Pomegranate Ellagitannin Extract

Pomegranate ellagitannin extract is a concentrated source of ellagitannins (such as punicalagins) and…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). What are the potential therapeutic roles and molecular mechanisms of urolithins, particularly urolithin A, in various diseases and antiaging? [Plain-English summary of Phytother Res 2021, PMID 34542202, DOI 10.1002/ptr.7290]. Magellan Longevity. https://magellanlongevity.com/study/s110.html
BibTeX
@misc{magellan_s110, title = {What are the potential therapeutic roles and molecular mechanisms of urolithins, particularly urolithin A, in various diseases and antiaging?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s110.html}}, note = {Plain-English summary of PubMed PMID 34542202; DOI 10.1002/ptr.7290; Phytother Res 2021. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s110.html

Related studies in the Magellan library

All 17 Magellan summaries on nad⁺, sirtuins & cellular energy →

How this summary was made. Every section above restates what the published abstract of PMID 34542202 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.